Intensity of transmission and spread of gene mutations linked to chloroquine and sulphadoxine-pyrimethamine resistance in falciparum malaria

International Journal for Parasitology

Volumn 33, Issue 10, 2003, Pages 1051-1058

  Talisuna, Ambrose O ^a,e   Langi, Peter ^a   Mutabingwa, Theonest K ^b,c   Van Marck, Eric ^d   Speybroeck, Niko ^e   Egwang, Thomas G ^f   Watkins, William W ^g   Hastings, Ian M ^h   D'Alessandro, Umberto ^e  

^a MINISTRY OF HEALTH   (Uganda)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^f Med Biotech Laboratories Uganda   (Uganda)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

^h LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Chloroquine; Drug resistance; Gene mutation; Malaria transmission intensity; Plasmodium falciparum; Sulphadoxine pyrimethamine

Indexed keywords

CHLOROQUINE; FANSIDAR;

MALARIA; MUTATION; PARASITE INTENSITY; PARASITE TRANSMISSION;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; FEMALE; GENE MUTATION; GENETIC CODE; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MOLECULAR CLONING; MORTALITY; NEWBORN; PLASMODIUM FALCIPARUM; PREVALENCE; RISK ASSESSMENT; UGANDA;

PLASMODIUM FALCIPARUM;

EID: 0142061037     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(03)00156-5     Document Type: Article

References (36)

1. Arnot D. Unstable malaria in Sudan: the influence of the dry season. Clone multiplicity of Plasmodium falciparum infections in individuals exposed to variable levels of disease transmission. Trans. R. Soc. Trop. Med. Hyg. 92:1998;580-585.
2. Babiker A., Walliker D. Current views on the population structure of Plasmodium falciparum: implications for control. Parasitol. Today. 13:1997;262-267.
3. Beier J.C., Killeen G.F., Githure J.I. Short report: entomological inoculation rates and Plasmodium falciparum malaria prevalence in Africa. Am. J. Trop. Med. Hyg. 61:1999;109-113.
4. Cattani J.A., Moir J.S., Gibson F.D., Ginny M., Paino J., Davidson W., Alpers M.P. Small area variations in the epidemiology of malaria in Madang Province. Papua New Guinea Med. J. 29:1985;11-17.
5. Djimde A., Doumbo O.K., Cortese J.F., Kayentao K., Doumbo S., Diourte Y., Dicko A., Su X.Z., Nomura T., Fidock D.A., Wellems T.E., Plowe C.V., Coulibaly D. A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 344:2001;257-263.
6. Djimde A., Doumbo O.K., Steketee R.W., Plowe C.V. Application of a molecular marker for surveillance of chloroquine- resistant falciparum malaria. Lancet. 358:2001;890-891.
7. Farnert A., Rooth I., Svensson A., Snounou G., Bjorkman A. Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children. J. Infect. Dis. 179:1999;989-995.
8. Fidock D.A., Nomura T., Talley A.K., Cooper R.A., Dzekunov S.M., Ferdig M.T., Ursos L.M., Sidhu A.B., Naude B., Deitsch K.W., Su X.Z., Wootton J.C., Roepe P.D., Wellems T.E. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell. 6:2000;861-871.
9. Foote S.J., Kyle D.E., Martin R.K., Oduola A.M., Forsyth K., Kemp D.J., Cowman A.F. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature. 345:1990;255-258.
10. Hastings I.M. A model for the origins and spread of drug-resistant malaria. Parasitology. 115:1997;133-141.
11. Hastings I.M., D'Alessandro U. Modelling a predictable disaster: the rise and spread of drug- resistant malaria. Parasitol. Today. 16:2000;340-347.
12. Hastings I.M., Bray P.G., Ward S.A. Parasitology. A requiem for chloroquine. Science. 298:2002;74-75.
13. Hill W.G., Babiker H.A., Ranford-Cartwright L.C., Walliker D. Estimation of inbreeding coefficients from genotypic data on multiple alleles, and application to estimation of clonality in malaria parasites. Genet. Res. 65:1995;53-61.
14. Kublin J.G., Dzinjalamala F.K., Kamwendo D.D., Malkin E.M., Cortese J.F., Martino L.M., Mukadam R.A., Rogerson S.J., Lescano A.G., Molyneux M.E., Winstanley P.A., Chimpeni P., Taylor T.E., Plowe C.V. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J. Infect. Dis. 185:2002;380-388.
15. Mberu E.K., Nzila A.M., Nduati E., Ross A., Monks S.M., Kokwaro G.O., Watkins W.M., Hopkins-Sibley C. Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance. Exp. Parasitol. 101:2002;90-96.
16. Mbogo C.N.M., Snow R.W., Khamala C.P.M., Kabiru E.W., Ouma J.H., Githure J.I., Marsh K., Beier J.C. Relationships between Plasmodium falciparum transmission by vector populations and the incidence of severe disease at nine sites on the Kenyan coast. Am. J. Trop. Med. Hyg. 52:1995;201-206.
17. Metselaar D., Van Thiel P.H. Classification of malaria. Trop. Geog. Med. 11:1959;157-161.
18. Nzila A.M., Mberu E.K., Sulo J., Dayo H., Winstanley P.A., Sibley C.H., Watkins W.M. Towards an understanding of the mechanism of pyrimethamine- sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. Antimicrob. Agents Chemother. 44:2000;991-996.
19. Paul R.E., Packer M.J., Walmsley M., Lagog M., Ranford-Cartwright L.C., Paru R., Day K.P. Mating patterns in malaria parasite populations of Papua New Guinea. Science. 269:1995;1709-1711.
20. Peterson D.S., Milhous W.K., Wellems T.E. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. USA. 87:1990;3018-3022.
21. Plowe C.V., Cortese J.F., Djimde A., Nwanyanwu O.C., Watkins W.M., Winstanley P.A., Estrada-Franco J.G., Mollinedo R.E., Avila J.C., Cespedes J.L., Carter D., Doumbo O.K. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J. Infect. Dis. 176:1997;1590-1596.
22. Ranford-Cartwright L.C., Taylor J., Umasunthar T., Taylor L.H., Babiker H.A., Lell B., Schmidt-Ott J.R., Lehman L.G., Walliker D., Kremsner P.G. Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans. R. Soc. Trop. Med. Hyg. 91:1997;719-724.
23. Reed M.B., Saliba K.J., Caruana S.R., Kirk K., Cowman A.F. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature. 403:2000;906-909.
24. Schneider G., Premji Z., Felger I., Smith T., Abdulla S., Beck H.P., Mshinda H. A point mutation in codon 76 of pfcrt is positively selected for by chloroquine treatment in Tanzania. Infect. Genet. Evol. 1:2002;183-189.
25. Schwick P., Eggelte T.A., Hess F., Tueumuna T.T., Payne D., Nothdurft H.D., von Sonnenburg F., Loscher T. Sensitive ELISA dipstick test for the detection of chloroquine in urine under field conditions. Trop. Med. Int. Health. 3:1998;828-832.
26. Sibley C.H., Hyde J.E., Sims P.F., Plowe C.V., Kublin J.G., Mberu E.K., Cowman A.F., Winstanley P.A., Watkins W.M., Nzila A.M. Pyrimethamine- sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 17:2001;582-588.
27. Sidhu A.B., Verdier-Pinard D., Fidock D.A. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science. 298:2002;210-213.
28. Snow R.W., Marsh K. The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv. Parasitol. 52:2002;235-264.
29. Snow R.W., Omumbo J.A., Lowe B., Molyneux C.S., Obiero J.O., Palmer A., Weber M.W., Pinder M., Nahlen B., Obonyo C., Newbold C., Gupta S., Marsh K. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet. 349:1997;1650-1654.
30. Talisuna A.O., Langi P., Bakyaita N., Egwang T., Mutabingwa T.K., Watkins W., Van Marck E., D'Alessandro U. Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors? Trans. R. Soc. Trop. Med. Hyg. 96:2002;310-317.
31. Talisuna A.O., Kyosiimire-Lugemwa J., Langi P., Mutabingwa T.K., Watkins W., Van Marck E., Egwang T., D'Alessandro U. Role of the pfcrt codon 76 mutation as a molecular marker for population-based surveillance of chloroquine (CQ)-resistant Plasmodium falciparum malaria in Ugandan sentinel sites with high CQ resistance. Trans. R. Soc. Trop. Med. Hyg. 96:2002;551-556.
32. Watkins W.M., Mosobo M. Treatment of Plasmodium falciparum malaria with pyrimethamine- sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Trans. R. Soc. Trop. Med. Hyg. 87:1993;75-78.
33. Wellems T.E., Plowe C.V. Chloroquine-resistant malaria. J. Infect. Dis. 184:2001;770-776.
34. White N. Antimalarial drug resistance and combination chemotherapy. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354:1999;739-749.
35. White N.J., Pongtavornpinyo W. The de novo selection of drug resistant malaria parasites. Proc. R. Soc. Lond. B Biol. Sci. 270:2003;545-554.
36. Zar J.H. Biostatistical Analysis. 2nd Edition:1984;Prentice-Hall International, Englewood Cliffs, NJ.